CHM 10.0% 2.2¢ chimeric therapeutics limited

Chimeric: Media Thread, page-712

  1. 12,378 Posts.
    lightbulb Created with Sketch. 3783
    iwCAR-T 2024 Presentations & discussions (vjhemonc.com)

    Scroll down to

    Allogeneic CAR NK cells in adults with AML or MDS
    May Daher MD Anderson Cancer Center, Houston, TX, United States


    This is the center where CHM does its current AML-NK trial. This is a new research about improving NK-cell CAR-T.

    Highlights some difficulties and how to overcome them. But proves that CHM's NK platform could become a huge platform for a variety of applications. If MDA researchers spent time and resources to work with NK-cells then there must be a lot to it.

    Be patient guys.

    GLTA
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.002(10.0%)
Mkt cap ! $18.39M
Open High Low Value Volume
2.2¢ 2.2¢ 2.0¢ $21.40K 1.025M

Buyers (Bids)

No. Vol. Price($)
5 385342 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 255138 3
View Market Depth
Last trade - 14.29pm 24/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.